These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1723621)

  • 1. Octamer-dependent regulation of the kFGF gene in embryonal carcinoma and embryonic stem cells.
    Schoorlemmer J; Kruijer W
    Mech Dev; 1991 Dec; 36(1-2):75-86. PubMed ID: 1723621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulatory sequences required for hst-1 expression in embryonal carcinoma cells.
    Koda T; Hasan S; Sasaki A; Arimura Y; Kakinuma M
    FEBS Lett; 1994 Mar; 342(1):71-5. PubMed ID: 8143853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of Oct-4 gene expression during differentiation of EC cells.
    Schoorlemmer J; Jonk L; Sanbing S; van Puijenbroek A; Feijen A; Kruijer W
    Mol Biol Rep; 1995; 21(3):129-40. PubMed ID: 8832901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of a negative retinoic acid response element in the murine Oct4 promoter.
    Schoorlemmer J; van Puijenbroek A; van Den Eijnden M; Jonk L; Pals C; Kruijer W
    Mol Cell Biol; 1994 Feb; 14(2):1122-36. PubMed ID: 8289793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extinction of Oct-3/4 gene expression in embryonal carcinoma x fibroblast somatic cell hybrids is accompanied by changes in the methylation status, chromatin structure, and transcriptional activity of the Oct-3/4 upstream region.
    Ben-Shushan E; Pikarsky E; Klar A; Bergman Y
    Mol Cell Biol; 1993 Feb; 13(2):891-901. PubMed ID: 7678695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NF-Y binds to the CCAAT box motif of the FGF-4 gene and promotes FGF-4 expression in embryonal carcinoma cells.
    Lamb KA; Johnson LR; Rizzino A
    Mol Reprod Dev; 1997 Nov; 48(3):301-9. PubMed ID: 9322240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptional regulation of the int-2 gene in embryonal carcinoma cells.
    Grinberg D; Thurlow J; Watson R; Smith R; Peters G; Dickson C
    Cell Growth Differ; 1991 Mar; 2(3):137-43. PubMed ID: 1647813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction between a novel F9-specific factor and octamer-binding proteins is required for cell-type-restricted activity of the fibroblast growth factor 4 enhancer.
    Dailey L; Yuan H; Basilico C
    Mol Cell Biol; 1994 Dec; 14(12):7758-69. PubMed ID: 7969117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An upstream NF-Y-binding site is required for transcriptional activation from the hst promoter in F9 embryonal carcinoma cells.
    Hasan S; Koda T; Kakinuma M
    J Biol Chem; 1994 Oct; 269(40):25042-8. PubMed ID: 7929190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of the Oct-4 gene by nuclear receptors.
    Sylvester I; Schöler HR
    Nucleic Acids Res; 1994 Mar; 22(6):901-11. PubMed ID: 8152920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repression of the IgH enhancer in teratocarcinoma cells associated with a novel octamer factor.
    Lenardo MJ; Staudt L; Robbins P; Kuang A; Mulligan RC; Baltimore D
    Science; 1989 Jan; 243(4890):544-6. PubMed ID: 2536195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential expression of jun and fos genes during differentiation of mouse P19 embryonal carcinoma cells.
    de Groot RP; Schoorlemmer J; van Genesen ST; Kruijer W
    Nucleic Acids Res; 1990 Jun; 18(11):3195-202. PubMed ID: 2113273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding of transcription factors to widely-separated cis-regulatory elements of the murine FGF-4 gene.
    Lamb K; Rosfjord E; Brigman K; Rizzino A
    Mol Reprod Dev; 1996 Aug; 44(4):460-71. PubMed ID: 8844688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergy of SF1 and RAR in activation of Oct-3/4 promoter.
    Barnea E; Bergman Y
    J Biol Chem; 2000 Mar; 275(9):6608-19. PubMed ID: 10692469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Orphan nuclear receptor GCNF is required for the repression of pluripotency genes during retinoic acid-induced embryonic stem cell differentiation.
    Gu P; LeMenuet D; Chung AC; Mancini M; Wheeler DA; Cooney AJ
    Mol Cell Biol; 2005 Oct; 25(19):8507-19. PubMed ID: 16166633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developmental-specific activity of the FGF-4 enhancer requires the synergistic action of Sox2 and Oct-3.
    Yuan H; Corbi N; Basilico C; Dailey L
    Genes Dev; 1995 Nov; 9(21):2635-45. PubMed ID: 7590241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a transposon-related RNA down-regulated by retinoic acid in embryonal carcinoma and embryonic stem cells.
    Hirose T; Austin SJ; Jetten AM
    Exp Cell Res; 1995 Dec; 221(2):294-300. PubMed ID: 7493627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic activation of the fibroblast growth factor 4 enhancer by Sox2 and Oct-3 depends on protein-protein interactions facilitated by a specific spatial arrangement of factor binding sites.
    Ambrosetti DC; Basilico C; Dailey L
    Mol Cell Biol; 1997 Nov; 17(11):6321-9. PubMed ID: 9343393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retinoic acid-mediated down-regulation of Oct3/4 coincides with the loss of promoter occupancy in vivo.
    Minucci S; Botquin V; Yeom YI; Dey A; Sylvester I; Zand DJ; Ohbo K; Ozato K; Scholer HR
    EMBO J; 1996 Feb; 15(4):888-99. PubMed ID: 8631309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The POU homeodomain protein OCT3 as a potential transcriptional activator for fibroblast growth factor-4 (FGF-4) in human breast cancer cells.
    Wang P; Branch DR; Bali M; Schultz GA; Goss PE; Jin T
    Biochem J; 2003 Oct; 375(Pt 1):199-205. PubMed ID: 12841847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.